Depressive disorders and antidepressive therapy in outpatient and inpatient psychiatric treatment

被引:0
|
作者
Linden, M
Ludewig, K
Munz, T
机构
[1] Free Univ Berlin, Psychiat Klin & Poliklin, Forsch Grp Ambulante Therapie, D-14050 Berlin, Germany
[2] Wyeth Pharma GmbH, Med Abt, Munster, Germany
来源
NERVENARZT | 2001年 / 72卷 / 07期
关键词
depression; antidepressants; venlafaxine; inpatient; outpatient; medical care; health care system;
D O I
10.1007/s001150170076
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It is a question of great importance when psychiatric patients should be treated as inpatients or as outpatients. This decision depends on therapeutic as well as economic considerations. However in depression,as in other mental illnesses, many cases could reasonably be treated as in- or outpatients alike Despite the importance of this question,there is to our knowledge no epidemiological study which compares patients in inpatient and outpatient settings within the current German medical system. 1300 inpatients and 5376 outpatients were investigated using identical methodologies within a drug utilization study of the antidepressant venlafaxine. Inpatients were found to be more severely ill and have a recurrent course of illness and higher rates of comorbidity. Outpatients more often had a chronic course. inpatients were treated more often and with a wider variety of medication than outpatients, with the exception of phytopharmaceuticals. Venlafaxine was given in higher doses in the inpatient setting and combined more often with other psychotropic medications. Complaints of adverse drug reactions were comparable in bath groups. Nausea was the most frequent, reported by 9.7% of inpatients and 15.2% of outpatients. The data show that the distribution of patients in outpatient and inpatient settings corresponds to the stepwise structure of the German health care system.
引用
收藏
页码:521 / 528
页数:8
相关论文
共 50 条
  • [41] The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy
    Steinberg, Holger
    Kirkby, Kenneth C.
    Himmerich, Hubertus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (12) : 28841 - 28869
  • [42] Pharmacogenetic treatment of depressive disorders
    Lee, Min-Soo
    FUTURE NEUROLOGY, 2007, 2 (03) : 329 - 338
  • [43] Typical patterns of depressive disorders during outpatient psychotherapy and their prediction
    Altmann, Uwe
    Steyer, Rolf
    Kramer, Dietmar
    Steffanowski, Andres
    Wittmann, Werner W.
    von Heymann, Friedrich
    Auch, Emma
    Bruckmayer, Ellen
    Pfaffinger, Irmgard
    Fembacher, Andrea
    Strauss, Bernhard
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2015, 61 (02): : 156 - 172
  • [44] Effect of Personality Disorders on Course and Treatment Outcome of Behaviour Therapy in an Outpatient Sample
    Muszer, Kinga
    Bailer, Josef
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2011, 61 (07) : 303 - 310
  • [45] Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany
    Kulp W.
    Graf Von Der Schulenburg J.-M.
    Greiner W.
    The European Journal of Health Economics, 2005, 6 (4) : 317 - 321
  • [46] An economic evaluation of outpatient versus inpatient polyp treatment for abnormal uterine bleeding
    Diwakar, L.
    Roberts, T. E.
    Cooper, N. A. M.
    Middleton, L.
    Jowett, S.
    Daniels, J.
    Smith, P.
    Clark, T. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (04) : 625 - 631
  • [47] Demographic and clinical characteristics of rural, regional, and metropolitan inpatients during psychiatric inpatient eating disorders treatment
    Seiler, Natalie
    Ziegeler, Benjamin
    Stukel, Mikayla
    Gwee, Karen
    AUSTRALASIAN PSYCHIATRY, 2024,
  • [48] Emergency medical reviews and medical admission transfers during psychiatric inpatient eating disorders unit treatment
    Seiler, Natalie
    Ziegeler, Benjamin
    Sacco, Natalie
    Elzahaby, Nardine
    Gwee, Karen
    EATING BEHAVIORS, 2025, 57
  • [49] Psychiatric Comorbidities of Substance Use Disorders: Does Dual Diagnosis Predict Inpatient Detoxification Treatment Outcomes?
    Davis, Adrian
    McMaster, Patrick
    Christie, Daniel C.
    Yang, Anes
    Kruk, Jeffrey S.
    Fisher, Karen A.
    INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2023, 21 (06) : 3785 - 3799
  • [50] Tryptophan Hydroxylase as Novel Target for the Treatment of Depressive Disorders
    Matthes, Susann
    Mosienko, Valentina
    Bashammakh, Saleh
    Alenina, Natalia
    Bader, Michael
    PHARMACOLOGY, 2010, 85 (02) : 95 - 109